Total Payments
$16,887
2024 Payments
$110.00
Companies
10
Transactions
27
Medicare Patients
557
Medicare Billing
$84,126
Payment Breakdown by Category
Consulting$13,275 (78.6%)
Other$1,454 (8.6%)
Travel$1,290 (7.6%)
Food & Beverage$680.53 (4.0%)
Education$188.31 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,275 | 8 | 78.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,410 | 1 | 8.4% |
| Travel and Lodging | $1,290 | 4 | 7.6% |
| Food and Beverage | $680.53 | 10 | 4.0% |
| Education | $188.31 | 3 | 1.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $43.36 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $10,502 | 12 | $0 (2023) |
| PFIZER INC. | $4,385 | 2 | $0 (2017) |
| Boehringer Ingelheim International GmbH | $1,410 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $172.99 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $168.68 | 4 | $0 (2018) |
| Stryker Corporation | $110.00 | 2 | $0 (2024) |
| Gilead Sciences Inc | $44.00 | 1 | $0 (2017) |
| Servier Pharmaceuticals LLC | $43.36 | 1 | $0 (2021) |
| Stemline Therapeutics Inc. | $35.71 | 1 | $0 (2019) |
| Agios Pharmaceuticals, Inc. | $15.32 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.00 | 2 | Stryker Corporation ($110.00) |
| 2023 | $6,252 | 7 | AbbVie Inc. ($6,252) |
| 2022 | $2,210 | 3 | Boehringer Ingelheim International GmbH ($1,410) |
| 2021 | $1,591 | 4 | AbbVie Inc. ($1,375) |
| 2020 | $1,940 | 2 | AbbVie Inc. ($1,925) |
| 2019 | $185.71 | 2 | AbbVie, Inc. ($150.00) |
| 2018 | $168.68 | 4 | Novartis Pharmaceuticals Corporation ($168.68) |
| 2017 | $4,429 | 3 | PFIZER INC. ($4,385) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2024 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 04/30/2024 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 12/21/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,687.50 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $125.25 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Travel and Lodging | In-kind items and services | $97.89 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Travel and Lodging | In-kind items and services | $513.15 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $115.90 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,687.50 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,410.17 | General |
| 09/14/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $73.99 | General |
| 09/09/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 06/11/2021 | AbbVie Inc. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | In-kind items and services | $43.36 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2020 | AbbVie Inc. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2020 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug), IDHIFA | Education | Cash or cash equivalent | $15.32 | General |
| Category: Oncology | ||||||
| 07/26/2019 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2019 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 11/15/2018 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2018 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2018 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological), PROMACTA | Food and Beverage | In-kind items and services | $102.10 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2018 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2017 | Gilead Sciences Inc | — | Travel and Lodging | In-kind items and services | $44.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 111 | 171 | $86,016 | $14,029 |
| 2022 | 6 | 156 | 302 | $115,768 | $22,750 |
| 2021 | 6 | 138 | 276 | $101,571 | $21,152 |
| 2020 | 7 | 152 | 381 | $125,833 | $26,196 |
Total Patients
557
Total Services
1,130
Medicare Billing
$84,126
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 55 | $34,026 | $5,333 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 49 | $21,906 | $3,643 | 16.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $14,754 | $2,736 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 48 | $15,330 | $2,318 | 15.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 70 | $41,016 | $7,276 | 17.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 86 | $19,684 | $4,847 | 24.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 50 | $16,430 | $3,949 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 39 | $16,410 | $2,761 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 44 | $12,991 | $1,987 | 15.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $9,237 | $1,930 | 20.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 61 | $31,711 | $6,716 | 21.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 89 | $20,467 | $5,101 | 24.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 24 | 24 | $16,884 | $3,407 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 42 | $15,780 | $2,931 | 18.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 49 | $12,908 | $2,099 | 16.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 11 | $3,821 | $898.15 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 144 | $33,343 | $8,446 | 25.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 74 | $35,384 | $6,104 | 17.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 46 | $15,230 | $3,883 | 25.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 27 | 27 | $18,351 | $3,687 | 20.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 40 | $14,223 | $2,282 | 16.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 28 | $3,830 | $901.65 | 23.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 22 | $5,472 | $892.07 | 16.3% |
About Dr. William Blum, M.D
Dr. William Blum, M.D is a Hematology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013922863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Blum, M.D has received a total of $16,887 in payments from pharmaceutical and medical device companies, with $110.00 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($13,275).
As a Medicare-enrolled provider, Blum has provided services to 557 Medicare beneficiaries, totaling 1,130 services with total Medicare billing of $84,126. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Atlanta, GA
- Active Since 07/30/2006
- Last Updated 07/21/2022
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1013922863
Products in Payments
- VENCLEXTA (Drug) $10,352
- MYLOTARG (Drug) $634.87
- KYMRIAH (Biological) $116.23
- NA (Device) $110.00
- TIBSOVO (Drug) $58.68
- ILARIS (Biological) $52.45
- ELZONRIS (Drug) $35.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Atlanta
Sagar Lonial, M.d, M.D
Hematology — Payments: $1.1M
Hematology $1.1M
Edmund Waller, M.d, M.D
Hematology — Payments: $153,979
Hematology $153,979
Dr. Kenneth Braunstein, M.d, M.D
Hematology — Payments: $133,797
Hematology $133,797
Christine Kempton, M.d, M.D
Hematology — Payments: $117,064
Hematology $117,064
Jonathan Kaufman, M.d, M.D
Hematology — Payments: $106,242
Hematology $106,242
Manila Gaddh, M.d, M.D
Hematology — Payments: $18,960
Hematology $18,960